Small molecule · developed by Fresenius Kabi Usa
Chloroprocaine is an ester local anesthetic. Its ophthalmic gel formulation is applied to the ocular surface before procedures such as intravitreal injection in retinal disease studies, to provide anesthesia.
Summary written with AI from the sources listed at the end of this page.
From the indications section of the FDA label (version of Mar 24, 2026). Read the full label for the exact wording, limitations and safety information.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT07779356 | Phase 4 | Macular Degeneration | Completed | HROW |
| NCT07456826 | Phase 4 | Diabetic Macular Edema (DME) | Enrolling by invitation | HROW |
| NCT05934253 | Phase 4 | Antiseptic | Completed | HROW |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Age-Related Macular Degeneration (AMD)Diabetic Macular Edema (DME)Diabetic Retinopathy (DR)Retinal Vein OcclusionAnesthesia, LocalAntisepticDiabetic RetinopathyMacular DegenerationRetinal Vein Occlusion (RVO)
Updated Oct 18, 2026.